BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 31622334)

  • 1. Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study.
    Ochs A; McGurnaghan S; Black MW; Leese GP; Philip S; Sattar N; Styles C; Wild SH; McKeigue PM; Colhoun HM;
    PLoS Med; 2019 Oct; 16(10):e1002945. PubMed ID: 31622334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of retinopathy progression using deep learning on retinal images within the Scottish screening programme.
    Mellor J; Jiang W; Fleming A; McGurnaghan SJ; Blackbourn LAK; Styles C; Storkey A; McKeigue PM; Colhoun HM
    Br J Ophthalmol; 2024 May; 108(6):833-839. PubMed ID: 38316534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualised screening for diabetic retinopathy: the ISDR study-rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening.
    Broadbent DM; Sampson CJ; Wang A; Howard L; Williams AE; Howlin SU; Appelbe D; Moitt T; Cheyne CP; Rahni MM; Kelly J; Collins J; García-Fiñana M; Stratton IM; James M; Harding SP;
    BMJ Open; 2019 Jun; 9(6):e025788. PubMed ID: 31213445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme.
    Looker HC; Nyangoma SO; Cromie DT; Olson JA; Leese GP; Philip S; Black MW; Doig J; Lee N; Briggs A; Hothersall EJ; Morris AD; Lindsay RS; McKnight JA; Pearson DW; Sattar NA; Wild SH; McKeigue P; Colhoun HM;
    Diabetologia; 2013 Aug; 56(8):1716-25. PubMed ID: 23689796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.
    Scotland G; McKeigue P; Philip S; Leese GP; Olson JA; Looker HC; Colhoun HM; Javanbakht M
    Diabet Med; 2016 Jul; 33(7):886-95. PubMed ID: 27040994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
    Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
    Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.
    Wolf RM; Channa R; Abramoff MD; Lehmann HP
    JAMA Ophthalmol; 2020 Oct; 138(10):1063-1069. PubMed ID: 32880616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme.
    Looker HC; Nyangoma SO; Cromie DT; Olson JA; Leese GP; Black MW; Doig J; Lee N; Lindsay RS; McKnight JA; Morris AD; Pearson DW; Philip S; Wild SH; Colhoun HM; ;
    Br J Ophthalmol; 2014 Jun; 98(6):790-5. PubMed ID: 24599419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year incidence and assessment of safe screening intervals for diabetic retinopathy: the OPHDIAT study.
    Chamard C; Daien V; Erginay A; Gautier JF; Villain M; Tadayoni R; Carriere I; Massin P
    Br J Ophthalmol; 2021 Mar; 105(3):432-439. PubMed ID: 32522790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extending the diabetic retinopathy screening intervals in Singapore: methodology and preliminary findings of a cohort study.
    Aravindhan A; Fenwick EK; Chan AWD; Man REK; Tan NC; Wong WT; Soo WF; Lim SW; Wee SY; Sabanayagam C; Finkelstein E; Tan G; Hamzah H; Chakraborty B; Acharyya S; Shyong TE; Scanlon P; Wong TY; Lamoureux EL
    BMC Public Health; 2024 Mar; 24(1):786. PubMed ID: 38481239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.
    Vujosevic S; Pucci P; Casciano M; Daniele A; Bini S; Berton M; Cavarzeran F; Avogaro A; Lapolla A; Midena E
    J Diabetes Complications; 2017 Aug; 31(8):1348-1353. PubMed ID: 28551296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center.
    Porter M; Channa R; Wagner J; Prichett L; Liu TYA; Wolf RM
    Pediatr Diabetes; 2020 Aug; 21(5):856-862. PubMed ID: 32410329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a model for the prediction of retinopathy in persons with type 1 diabetes.
    Schreur V; Ng H; Nijpels G; Stefánsson E; Tack CJ; Klevering BJ; de Jong EK; Hoyng CB; Keunen JEE; van der Heijden AA
    Br J Ophthalmol; 2021 Sep; 105(9):1286-1288. PubMed ID: 30824420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis.
    Thomas RL; Dunstan F; Luzio SD; Roy Chowdury S; Hale SL; North RV; Gibbins RL; Owens DR
    BMJ; 2012 Feb; 344():e874. PubMed ID: 22362115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of diabetic retinopathy in type 1 diabetes in a diabetes care center in South India-Feasibility and awareness improvement study.
    Rajalakshmi R; Shanthirani CS; Anandakumar A; Anjana RM; Murthy GVS; Gilbert C; Mohan V
    Indian J Ophthalmol; 2020 Feb; 68(Suppl 1):S92-S95. PubMed ID: 31937740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.
    Wang SY; Andrews CA; Herman WH; Gardner TW; Stein JD
    Ophthalmology; 2017 Apr; 124(4):424-430. PubMed ID: 27914837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Diabetic Retinal Screening and Factors for Ophthalmology Referral in a Telemedicine Network.
    Jani PD; Forbes L; Choudhury A; Preisser JS; Viera AJ; Garg S
    JAMA Ophthalmol; 2017 Jul; 135(7):706-714. PubMed ID: 28520833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First diabetic retinopathy prevalence study in Portugal: RETINODIAB Study--evaluation of the screening programme for Lisbon and Tagus Valley region.
    Dutra Medeiros M; Mesquita E; Papoila AL; Genro V; Raposo JF
    Br J Ophthalmol; 2015 Oct; 99(10):1328-33. PubMed ID: 25837605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic Retinopathy Screening in Patients with Diabetes Using a Handheld Fundus Camera: The Experience from the South-Eastern Region in Hungary.
    Eszes DJ; Szabó DJ; Russell G; Lengyel C; Várkonyi T; Paulik E; Nagymajtényi L; Facskó A; Petrovski G; Petrovski BÉ
    J Diabetes Res; 2021; 2021():6646645. PubMed ID: 33628836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland.
    Looker HC; Nyangoma SO; Cromie D; Olson JA; Leese GP; Black M; Doig J; Lee N; Lindsay RS; McKnight JA; Morris AD; Philip S; Sattar N; Wild SH; Colhoun HM; ;
    Diabetologia; 2012 Sep; 55(9):2335-42. PubMed ID: 22688348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.